Related Articles
Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review)
How specific molecular‑targeted agents can make obsolete a ‘one size fits all’ approach in <em>EGFR</em>‑mutated NSCLC treatment (Review)
Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review)
Role of radio‑ablative technique for optimizing the survival of patients with locally advanced pancreatic adenocarcinoma (Review)
Update on uveal melanoma: Translational research from biology to clinical practice (Review)